The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction.
Articles > Article · 2019
Authors: C Paitazoglou, R Özdemir, R Pfister, MW Bergmann, J Bartunek, T Kilic, A Lauten, A Schmeisser, Mehdi ZOGHİ, S Anker, H Sievert, F Mahfoud
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Journal Indexed in SCI Expanded, International, 2019, vol 15, pp 403-410